The effect of progesterone in patients with premature rupture of membranes
- Conditions
- Premature rupture of membranes, labour delayed by therapy.Premature rupture of membranes, labour delayed by therapy
- Registration Number
- IRCT201512077676N4
- Lead Sponsor
- Vice Chancellor for Research and Technology University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
pregnant women with gestational age between 26 to 32 weeks with premature rupture of membranes (PROM); signing informed consent.
Exclusion criteria: fetal abnormalities; genetic abnormalities that can affect fetal growth that have been checked by ultrasound at 18 to 20 weeks and 28 to 32 weeks. Along with trisomy screening marker with double or quad marker; precambrian patients; chronic high blood pressure; overt diabetes; pregnancy-related diabetes; detachment; prolapsed umbilical cord; chorioamnionitis; gestational age over 32 weeks (because there isn’t sufficient time to study the effects of progesterone); patient who have had a rupture of the membranes after 36 hours; patient who are in active phase.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method engthening the interval between the pre-term delivery runny. Timepoint: Daily. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method Improving Perinatal Outcomes. Timepoint: Follow baby daily until discharge. Method of measurement: Physical examination.